Relanab 750 Tablet

About Relanab 750 Tablet

Relanab 750 comes as a tablet with 750 mg of Nabumetone, from Opsonin Pharma Limited. In rheumatoid arthritis, it helps reduce pain and swelling.

There are 28 brands of Nabumetone listed in Bangladesh. The lowest listed price is Relanab 500 mg Tablet at ৳ 15 per unit.

What is Relanab 750 Tablet?

Relanab 750 750 mg is a tablet product of Opsonin Pharma Limited that contains Nabumetone. It belongs to a group of medicines used for osteoarthritis. It is intended for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. The dose and length of treatment are chosen by the doctor for each patient.

Uses of Relanab 750

In rheumatoid arthritis, it helps reduce pain and swelling. Relanab 750 is used to relieve signs and symptoms of osteoarthritis and rheumatoid arthritis. Before starting it, the doctor weighs the possible benefits against the possible risks and considers other treatment options. Ask your doctor if you are unsure whether this medicine is right for your condition.

How to use Relanab 750

Swallow the tablet with water. Relanab 750 is taken by mouth. Follow your doctor's instructions carefully. Tell your doctor about all other medicines you take, because NSAIDs can interact with some medicines, including ACE inhibitors. Complete the course exactly as prescribed.

Side effects of Relanab 750

Some people may have side effects while taking Relanab 750. The most common are diarrhoea, indigestion and abdominal pain. Some people notice dizziness, headache, tiredness, sweating, trouble sleeping, nervousness or drowsiness. Tell your doctor about any side effect that bothers you or does not go away.

Safety and precautions

It is not known whether it passes into human breast milk, so discuss breastfeeding with your doctor. In pregnancy, it should be used only if the doctor decides the benefit justifies the risk; there are no adequate studies in pregnant women. Pregnancy category C means it should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Tell your doctor about all the other medicines you take.

Frequently asked questions

What does Relanab 750 treat?

In rheumatoid arthritis, it helps reduce pain and swelling. Relanab 750 is used to relieve signs and symptoms of osteoarthritis and rheumatoid arthritis.

How is Relanab 750 used?

Swallow the tablet with water. Relanab 750 is taken by mouth.

What should I watch for while using Relanab 750?

Some people may have side effects while taking Relanab 750. The most common are diarrhoea, indigestion and abdominal pain.

Can I use Relanab 750 in pregnancy or while breastfeeding?

It is not known whether it passes into human breast milk, so discuss breastfeeding with your doctor. In pregnancy, it should be used only if the doctor decides the benefit justifies the risk; there are no adequate studies in pregnant women.

Indications

Nabumetone is indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. Carefully consider the potential benefits and risks of Nabumetone and other treatment options before deciding to use Nabumetone. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals

Pharmacology

Nabumetone is a naphthylalkanone. Is is a non-selective prostaglandin G/H synthase (a.k.a. cyclooxygenase or COX) inhibitor that acts on both prostaglandin G/H synthase 1 and 2 (COX-1 and -2). Prostaglandin G/H synthase catalyzes the conversion of arachidonic acid to prostaglandin G2 and prostaglandin G2 to prostaglandin H2. Prostaglandin H2 is the precursor to a number of prostaglandins involved in fever, pain, swelling, inflammation, and platelet aggregation. The parent compound is a prodrug that undergoes hepatic biotransformation to the active compound, 6-methoxy-2-naphthylacetic acid (6MNA). The analgesic, antipyretic and anti-inflammatory effects of NSAIDs occur as a result of decreased prostaglandin synthesis.

The parent compound is a prodrug, which undergoes hepatic biotransformation to the active component, 6-methoxy-2-naphthylacetic acid (6MNA), that is a potent inhibitor of prostaglandin synthesis, most likely through binding to the COX-2 and COX-1 receptors.

Dosage & Administration

Osteoarthritis and Rheumatoid Arthritis: The recommended starting dose is 1,000 mg taken as a single dose with or without food. Some patients may obtain more symptomatic relief from 1,500 mg to 2,000 mg per day. Nabumetone can be given in either a single or twice-daily dose. Dosages greater than 2,000 mg per day have not been studied. The lowest effective dose should be used for chronic treatment.  Patients weighing under 50 kg may be less likely to require dosages beyond 1,000 mg; therefore, after observing the response to initial therapy, the dose should be adjusted to meet individual patients’ requirements.

Interaction

Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE-inhibitors. This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE-inhibitors.

Contraindications

Nabumetone is contraindicated in patients with known hypersensitivity to nabumetone or its excipients. Nabumetone should not be given to patients who have experienced asthma, urticaria, or allergictype reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nabumetone is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery

Side Effects

Gastrointestinal: Diarrhea (14%), dyspepsia (13%), abdominal pain (12%), constipation, flatulence, nausea, positive stool guaiac, dry mouth, gastritis, stomatitis, vomiting.

Central Nervous System: Dizziness, headache, fatigue, increased sweating, insomnia, nervousness, somnolence.

Dermatologic: Pruritus, rash

Special Senses: Tinnitus

Miscellaneous: Edema

Pregnancy & Lactation

Pregnancy Category C. Reproductive studies conducted in rats and rabbits have not demonstrated evidence of developmental abnormalities. However, animal reproduction studies are not always predictive of human response. There are no adequate, well-controlled studies in pregnant women. Nabumetone should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers: It is not known whether this drug is excreted in human milk, however 6MNA is excreted in the milk of lactating rats. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Nabumetone, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Labor and Delivery: In rat studies with NSAIDs, as with other drugs known to inhibit prostaglandin synthesis, an increased incidence of dystocia, delayed parturition, and decreased pup survival occurred. The effects of Nabumetone on labor and delivery in pregnant women are unknown.

Precautions & Warnings

Nabumetone cannot be expected to substitute for corticosteroids or to treat corticosteroid insufficiency. Abrupt discontinuation of corticosteroids may lead to disease exacerbation. Patients on prolonged corticosteroid therapy should have their therapy tapered slowly if a decision is made to discontinue corticosteroids. The pharmacological activity of Nabumetone in reducing fever and inflammation may diminish the utility of these diagnostic signs in detecting complications of presumed noninfectious, painful conditions

Overdose Effects

Symptoms following acute NSAIDs overdoses are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Hypertension, acute renal failure, respiratory depression, and coma may occur, but are rare. Anaphylactoid reactions have been reported with therapeutic ingestion of NSAIDs, and may occur following an overdose.

Patients should be managed by symptomatic and supportive care following a NSAIDs overdose. There are no specific antidotes. Emesis and/or activated charcoal (60 to 100 grams in adults, 1 to 2 g/kg in children), and/or osmotic cathartic may be indicated in patients seen within 4 hours of ingestion with symptoms or following a large overdose (5 to 10 times the usual dose). Forced diuresis, alkalinization of urine, hemodialysis, or hemoperfusion may not be useful due to high protein binding.

There have been overdoses of up to 25 grams of Nabumetone reported with no long-term sequelae following standard emergency treatment (i.e., activated charcoal, gastric lavage, IV H2-blockers, etc.).

Storage Conditions

Store at 25°C; excursions permitted to 15-30°C in well-closed container; dispense in light-resistant container.

Alternative brands of Nabumetone

Other brands with the same generic name, cheapest first.

Buflex Tablet

500 mg

Nabumetone

Beximco Pharmaceuticals Ltd.

৳ 15.00 per unit

Buflex Tablet

750 mg

Nabumetone

Beximco Pharmaceuticals Ltd.

৳ 22.00 per unit

Buflex Tablet

1000 mg

Nabumetone

Beximco Pharmaceuticals Ltd.

৳ 30.00 per unit

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.